Related references
Note: Only part of the references are listed.Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery
Jing Xu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Persistent Dystrophin Protein Restoration 90 Days after a Course of Intraperitoneally Administered Naked 2′OMePS AON and ZM2 NP-AON Complexes in mdx Mice
Elena Bassi et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin
Yueling Zhang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak et al.
LANCET (2011)
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Nathalie M. Goemans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
C. Frank Bennett et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Polymer integrity related absorption mechanism of superporous hydrogel containing interpenetrating polymer networks for oral delivery of insulin
Lichen Yin et al.
BIOMATERIALS (2010)
Microcapsules of alginate/chitosan containing magnetic nanoparticles for controlled release of insulin
Priscilla Vanessa Finotelli et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Immunogenic and protective effects of an oral DNA vaccine against infectious pancreatic necrosis virus in fish
Ana I. de las Heras et al.
FISH & SHELLFISH IMMUNOLOGY (2010)
Drug-Loaded Nanoparticles Targeted to the Colon With Polysaccharide Hydrogel Reduce Colitis in a Mouse Model
Hamed Laroui et al.
GASTROENTEROLOGY (2010)
Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP-AON complexes
A. Ferlini et al.
GENE THERAPY (2010)
Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model
Hans Heemskerk et al.
MOLECULAR THERAPY (2010)
Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic
Sam Maher et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Efficacy of Systemic Morpholino Exon-Skipping in Duchenne Dystrophy Dogs
Toshifumi Yokota et al.
ANNALS OF NEUROLOGY (2009)
Exon Skipping-Mediated Dystrophin Reading Frame Restoration for Small Mutations
Pietro Spitali et al.
HUMAN MUTATION (2009)
Oral delivery of siRNA and antisense oligonucleotides
Saghir Akhtar
JOURNAL OF DRUG TARGETING (2009)
In vivo comparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping
Hans A. Heemskerk et al.
JOURNAL OF GENE MEDICINE (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. (vol 8, pg 918, 2009)
M. Kinali et al.
LANCET NEUROLOGY (2009)
Cationic PMMA Nanoparticles Bind and Deliver Antisense Oligoribonucleotides Allowing Restoration of Dystrophin Expression in the mdx Mouse
Paola Rimessi et al.
MOLECULAR THERAPY (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
Maria Kinali et al.
LANCET NEUROLOGY (2009)
The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles
Robert M. Samstein et al.
BIOMATERIALS (2008)
Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes
Ziyad S. Haidar et al.
BIOMATERIALS (2008)
Formation and oral administration of alginate microspheres loaded with pDNAcoding for lymphocystis disease virus (LCDV) to Japanese flounder
Ji-Yuan Tian et al.
FISH & SHELLFISH IMMUNOLOGY (2008)
Oral delivery of antisense oligonucleotides in man
Lloyd G. Tillman et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Exon skipping and Duchenne muscular dystrophy: Hope, hype and how feasible
Steve D. Wilton et al.
NEUROLOGY INDIA (2008)
Local dystrophin restoration with antisense oligonucleotide PRO051
Judith C. van Deutekom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles
Olga Borges et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Evaluation of alginate based mesalazine tablets for intestinal drug delivery
Fatmanur Tugcu-Demiroez et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
Anne des Rieux et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan - a review
Meera George et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates
NJ Kavimandan et al.
BIOMATERIALS (2006)
Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy
Y Takeshima et al.
PEDIATRIC RESEARCH (2006)
Antisense applications for biological control
WH Pan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses
Zahoor Ahmad et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs
YH Lin et al.
BIOMATERIALS (2005)
Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles
QL Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers
R Pandey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate
AA Raoof et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Alginate/poly-L-lysine microparticles for the intestinal delivery of antisense oligonucleotides
MG Ferreiro et al.
PHARMACEUTICAL RESEARCH (2002)
Bioavailability and efficacy of antisense morpholino oligomers targeted to c-myc and cytochrome P-450 3A2 following oral administration in rats
V Arora et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Alginate in drug delivery systems
HH Tonnesen et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2002)
Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse
CJ Mann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
